Literature DB >> 28658680

Submucosal fibrosis in achalasia patients is a rare cause of aborted peroral endoscopic myotomy procedures.

Qiu-Ning Wu1, Xiao-Yue Xu1, Xiao-Cen Zhang1, Mei-Dong Xu1, Yi-Qun Zhang1, Wei-Feng Chen1, Ming-Yan Cai1, Wen-Zheng Qin1, Jian-Wei Hu1, Li-Qing Yao1, Quan-Lin Li1, Ping-Hong Zhou1.   

Abstract

Background and aims Peroral endoscopic myotomy (POEM) is now an established treatment for esophageal achalasia. The standard protocol ensures a smooth operation in most patients, but technical challenges and failures exist and little is known about the incidence, causes, and impact of aborted procedures. Here, using a large patient cohort, we attempted to answer these questions. Methods All patients admitted for planned POEM between August 2010 and July 2015 underwent chart review. Aborted POEM was defined as the inability to finish the procedure after submucosal injection. The cause of the failure, clinical course, management, and follow-up data were analyzed. Results Thirteen of the 1693 POEMs (0.77 %) were aborted. Out of the 13 failures, 12 (92.3 %) were due to severe submucosal fibrosis, which precluded tunneling, and one (7.7 %) was due to atrial fibrillation related to the electric current of the endoscopic knife. Submucosal fibrosis, prior Heller myotomy, and age ( ≥ 60 years) were related to technical failure, while a disease duration of ≥ 6 years, sigmoid esophagus, mucosal edema, and prior interventions were risk factors for the presence of fibrotic changes. In turn, fibrosis was correlated with a prolonged operation, longer hospital stay, more mucosal injuries, and more major perioperative adverse events. Finally, the yearly frequency of aborted POEMs decreased after the second year as operators became more experienced. Conclusions Aborted POEM is a rare event and is largely due to the presence of submucosal fibrosis, which not only causes increased procedural difficulties, but also gives rise to major adverse events. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2017        PMID: 28658680     DOI: 10.1055/s-0043-113440

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  11 in total

1.  Peroral endoscopic myotomy is highly effective for achalasia patients with recurrent symptoms after pneumatic dilatation.

Authors:  Madhusudhan R Sanaka; George Khoudari; Malav Parikh; Prashanthi N Thota; Rocio Lopez; Niyati Gupta; Scott Gabbard; Monica Ray; Sudish Murthy; Siva Raja
Journal:  Surg Endosc       Date:  2020-06-18       Impact factor: 4.584

2.  Outcome of peroral endoscopic myotomy in children with achalasia.

Authors:  Zaheer Nabi; Mohan Ramchandani; Radhika Chavan; Santosh Darisetty; Rakesh Kalapala; Upender Shava; Manu Tandan; Rama Kotla; D Nageshwar Reddy
Journal:  Surg Endosc       Date:  2019-01-22       Impact factor: 4.584

3.  Long-Term Efficacy of Peroral Endoscopic Myotomy for Patients with Achalasia: Outcomes with a Median Follow-Up of 36 Months.

Authors:  Chenghai He; Meng Li; Bin Lu; Xiao Ying; Chen Gao; Shuangshuang Wang; Chengao Ma; Chaoqiong Jin
Journal:  Dig Dis Sci       Date:  2018-11-26       Impact factor: 3.199

4.  Outcomes of Per-Oral Endoscopic Myotomy in Children: A Systematic Review and Meta-analysis.

Authors:  Zaheer Nabi; Rupjyoti Talukdar; Radhika Chavan; Jahangeer Basha; D Nageshwar Reddy
Journal:  Dysphagia       Date:  2022-01-29       Impact factor: 3.438

5.  Short-term safety and efficacy of peroral endoscopic myotomy for the treatment of achalasia in children.

Authors:  Zuqiang Liu; Yun Wang; Ying Fang; Ying Huang; Hongbin Yang; Xiaoxia Ren; Meidong Xu; Shiyao Chen; Weifeng Chen; Yunshi Zhong; Yiqun Zhang; Wenzheng Qin; Jianwei Hu; Mingyan Cai; Liqing Yao; Quanlin Li; Pinghong Zhou
Journal:  J Gastroenterol       Date:  2019-11-02       Impact factor: 7.527

6.  Two-Stage Peroral Endoscopic Myotomy for Sigmoid-Type Achalasia.

Authors:  Hak Su Kim; Hee Kyung Kim; Weon Jin Ko
Journal:  Clin Endosc       Date:  2019-07-16

7.  Influence of esophageal morphology on the clinical efficacy of peroral endoscopic myotomy in treating advanced achalasia cardia.

Authors:  Dan Liu; Yue-Yuan Liu; Jia-Xin Chen; Lei Song; Yang-Yang Zhou; Saif Ullah; Li-Xia Zhao; Bin Hai; Qing-Fen Zheng; Dong-Ying Li; De-Zhi He; Bing-Rong Liu
Journal:  Exp Ther Med       Date:  2021-01-08       Impact factor: 2.447

8.  Outcome of peroral endoscopic myotomy in achalasia cardia: Experience with a new triangular knife.

Authors:  Zaheer Nabi; Mohan Ramchandani; Radhika Chavan; Rakesh Kalapala; Santosh Darisetty; D Nageshwar Reddy
Journal:  Saudi J Gastroenterol       Date:  2018 Jan-Feb       Impact factor: 2.485

9.  New endoscopic classification of esophageal mucosa in achalasia: A predictor for submucosal fibrosis.

Authors:  Xiuxue Feng; Enqiang Linghu; Ningli Chai; Hui Ding
Journal:  Saudi J Gastroenterol       Date:  2018 Mar-Apr       Impact factor: 2.485

10.  Gas Leak and Mucosal Injury During Endoscopic Esophageal Myotomy After Previous Myotomy: A Single-Center Experience.

Authors:  Salih Samo; Falak Hamo; Anand S Jain; Rushikesh H Shah; Vaishali Patel; Lucie F Calderon; Mengdan Xie; Parit Mekaroonkamol; Steven A Keilin; Qiang Cai
Journal:  Clin Exp Gastroenterol       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.